|
ZNF207 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.570600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.547400E-01 |
| Normal-vs-Stage2 |
3.533200E-01 |
| Normal-vs-Stage3 |
3.082200E-01 |
| Normal-vs-Stage4 |
5.704800E-01 |
| Stage1-vs-Stage2 |
1.846030E-01 |
| Stage1-vs-Stage3 |
8.790200E-02 |
| Stage1-vs-Stage4 |
3.060000E-01 |
| Stage2-vs-Stage3 |
9.479000E-01 |
| Stage2-vs-Stage4 |
6.348400E-01 |
| Stage3-vs-Stage4 |
5.994200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.691000E-01 |
| Normal-vs-AfricanAmerican |
3.021200E-01 |
| Normal-vs-Asian |
5.107400E-01 |
| Caucasian-vs-AfricanAmerican |
2.430200E-01 |
| Caucasian-vs-Asian |
3.519800E-01 |
| AfricanAmerican-vs-Asian |
7.012600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.502200E-01 |
| Normal-vs-Female |
7.872400E-01 |
| Male-vs-Female |
8.952400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.040400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.367200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.600400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.114600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.713430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.955700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.069000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.959800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.280600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.328200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.331380E-01 |
| Classical-VS-Follicular |
1.001670E-03 |
| Classical-VS-Other |
1.382000E-01 |
| Classical-VS-Normal |
3.591200E-01 |
| Tall-VS-Follicular |
4.163400E-01 |
| Tall-VS-Other |
5.463200E-01 |
| Tall-VS-Normal |
5.106000E-01 |
| Follicular-VS-Other |
9.191400E-01 |
| Follicular-VS-Normal |
6.033600E-02 |
| Other-VS-Normal |
2.658200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.335800E-01 |
| Normal-vs-N1 |
6.201000E-01 |
| N0-vs-N1 |
8.080800E-01 |
|
|
